×
ADVERTISEMENT

pertuzumab

How I Manage Adjuvant Therapy in HER2-Positive Breast Cancer

Adjuvant anti-HER2 therapy in combination with chemotherapy has markedly improved disease-free survival and overall ...

JULY 12, 2017

Pertuzumab Plus Trastuzumab Yields Small Benefit at Steep Price

Adding pertuzumab to trastuzumab for women with HER2-positive breast cancer reduced the risk for invasive breast ...

JUNE 1, 2017

AACR Report: HER2-Targeted Rx Effective in HER2+ mCRC

In heavily pretreated patients with HER2-positive mCRC, a combination of trastuzumab and lapatinib provided ...

APRIL 6, 2017

Load more